InnovAge Holding Corp. (INNV) Guidance & Earnings Results

On 2026-09-08 InnovAge Holding Corp. raised guidance: "FY2027 revenue guidance $1.05-1.085B vs FY2026 actual $989.7M; Adj. EBITDA $105-115M vs…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INNVInnovAge Holding Corp.Follow INNV — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 1.3B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 3 Nov, in 10 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
8 Sep 26	Raised	FY2027 revenue guidance $1.05-1.085B vs FY2026 actual $989.7M; Adj. EBITDA $105-115M vs $94.6M · full year
5 May 26	Raised	FY2026 total revenues raised to $950-975M; Adjusted EBITDA raised to $85-90M; Census unchanged at 7,900-8,100; Total Member Months unchanged at 92,900-95,700. · full year
3 Feb 26	Raised	FY26 total revenues raised to $925-950M (prior not stated); FY26 Adjusted EBITDA raised to $70-75M (prior not stated); FY26 census unchanged at 7,900-8,100; FY26 total member months 92,900-95,700. · full year
4 Nov 25	Reaffirmed	FY2026 Total revenues $900-950M; Adjusted EBITDA $56-65M; Census 7,900-8,100; Total Member Months 91,600-94,400 · full year
9 Sep 25	Raised	FY2026: Census 7,900-8,100; Total Member Months 91,600-94,400; Total revenues $900-950M; Adjusted EBITDA $56-65M · full year

InnovAge Holding Corp. — questions

What guidance did InnovAge Holding Corp. give?: On 2026-09-08: "FY2027 revenue guidance $1.05-1.085B vs FY2026 actual $989.7M; Adj. EBITDA $105-115M vs $94.6M"
When does InnovAge Holding Corp. report earnings?: InnovAge Holding Corp.'s next earnings report is expected on 2026-11-03.

Every figure on this page comes from InnovAge Holding Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.